【レポートの概要（一部）】
1. Report Overview
1.1 Leading Contract Manufacturing Organisations (CMOs) Overview
1.2 Benefits of This Report
1.3 How This Report Delivers Information
1.4 Main Questions This Report Answers
1.5 Who is This Report For?
1.6 Methods of Research and Analysis
1.7 Frequently Asked Questions (FAQs)
1.8 Some Related Reports
1.9 About Visiongain
2. Introduction to Pharmaceutical Contract Manufacturing, 2016
2.1 What Services Do Contract Manufacturers Offer?
2.1.1 Why Do Firms Outsource Manufacturing?
2.1.2 What Is Driving Demand for Contract Manufacturing Services?
2.2 The Pharmaceutical Contract Manufacturing Market, 2015
2.2.1 Where is Supply and Demand Highest for Contract Manufacturing Services?
2.3 Outlook for the Pharmaceutical Contract Manufacturing Market 2016-2026
2.4 Driving and Restrictive Forces for Pharmaceutical Contract Manufacturing, 2016-2026
2.4.1 Pharmaceutical Contract Manufacturing: Market Drivers 2016-2026
2.4.2 Pharmaceutical Contract Manufacturing: Market Restraints 2016-2026
2.5 Who Are the Leading Pharmaceutical Contract Manufacturers in 2015?
3. Leading CMOs in North America
3.1 Catalent Pharma Solutions- the World’s Leading CMO
3.1.1 Catalent: Manufacturing Services and Capabilities
3.1.2 Divisional Segmentation – Breaking Down Catalent’s Service
3.1.3 Catalent Pharma’s Revenue Growth, 2010-2014
3.1.4 Sustained Growth in Oral Products: Catalent Pharma’s Divisional Performance, 2010-2014
3.1.5 Catalent Is Expanding its Oral Technologies Division
3.1.6 Quadrupling Biopharmaceutical Manufacturing Capacity
3.1.7 Expansion of Packaging Services in Asia-Pacific and Europe: 2015
3.1.8 Adding New Early-Stage Development Services
3.1.9 Expansion in Japan – Growth Prospects for Catalent
3.1.10 New Business Contracts 2014-2015
3.1.11 Catalent New Products Launch
3.1.12 Catalent: Opportunities for Growth 2016-2026
3.1.13 Catalent: Mild Growth in Revenue, 2016-2026
3.2 Patheon – One of the Top 3 CMOs
3.2.1 Patheon – Global leader in Pharmaceutical Development Services
3.2.2 Contract Manufacturing Services at Patheon
3.2.3 Steady Revenue Growth 2010-2015
3.2.4 DPx Holdings: Developments
3.2.5 Adding New Formulations and Formulation Development Services
3.2.6 Reassessing Manufacturing Capacity
3.2.7 Expanding Services Through Acquisition, 2015
3.2.8 Patheon: SWOT Analysis 2016-2026
3.2.9 Patheon: Contract Manufacturing Revenue Forecast 2016-2026
3.3 Baxter BioPharma Solutions
3.3.1 Baxter BioPharma is the Global Leader in Sterile Fill and Finish
3.3.2 Historic Revenue Performance 2010-2015
3.3.3 Baxter BioPharma SWOT Analysis 2016-2026
3.3.4 Baxter BioPharma Revenue Forecast 2016-2026
3.4 AbbVie Contract Manufacturing
3.4.1 AbbVie Offers Full-Service Contract Manufacturing
3.4.2 Expanding and Adding New Services: 2013-2014
3.4.3 AbbVie Contract Manufacturing: Revenue 2011-2015
3.4.4 Biologics and HPAPIs Are an Opportunity for Growth 2016-2026
3.4.5 AbbVie Contract Manufacturing Revenue Forecast 2016-2026
3.5 Pfizer CentreOne
3.5.1 Pfizer CentreSource: Historic Revenue Performance, 2010-2015
3.5.2 Will Hospira Acquisition Lead to Revenue Growth in Future?
3.5.3 Outlook for CentreOne: Revenue Forecast 2016-2026
4. Leading European Contract Manufacturing Organisations
4.1 Lonza
4.1.1 Lonza Is a Leader in Biologics Manufacturing
4.1.2 Lonza Contract Manufacturing and Development: 2010-2015
4.1.3 Investing in Advanced Biological Drug Sectors
4.1.4 The Promise of Antibody-Drug Conjugates (ADCs)
4.1.5 The Regenerative Medicine Future in Japan
4.1.6 Lonza: SWOT Analysis 2016-2026
4.1.7 Biologics and Efficiency Savings Will Drive Growth in Revenue and Operating Profit for Lonza 2016-2026
4.2 Evonik Degussa
4.2.1 Investing in API and Drug Delivery Services
4.2.2 Moderate Growth in Pharmaceutical Manufacturing Services, 2010-2015
4.2.3 Evonik Is a HPAPI Specialist
4.2.4 Evonik Continues to Grow Across All Segments
4.2.5 How Can Evonik Expand in the Pharmaceutical Contract Manufacturing Market?
4.2.6 Evonik Degussa: Revenue Forecast 2016-2026
4.3 Royal DSM
4.3.1 Amplified Revenue Growth in Pharma Manufacturing 2010-2014
4.3.2 DSM Pharmaceuticals Products/DPx Holdings: Manufacturing Services 2010-2015
4.3.3 DSM Sinochem Pharmaceuticals: A World Leader in Antibacterial Manufacturing
4.3.4 DPx Holdings: A New Pharma Leader
4.3.5 Investing in Biopharma Manufacturing
4.3.6 Expanding API Manufacturing
4.3.7 Generics and Biologics Are an Opportunity for Growth, 2015-2026
4.3.8 DSM Pharmaceuticals Products: Revenue Forecast 2016-2026
4.4 Boehringer Ingelheim Contract Manufacturing
4.4.1 Expanding Biopharmaceuticals Manufacturing Services in China
4.4.2 Production Through to Fill and Finished Biopharmaceuticals
4.4.3 A Track Record of Production for 29 Biopharma Products
4.4.4 Increasing Revenue from Contract Manufacturing, 2010-2014
4.4.5 Pulling Out of Small Molecule API Manufacturing
4.4.6 Expanding through New Services
4.4.7 Boehringer Ingelheim Biopharmaceuticals: Opportunities for Growth 2016-2026
4.4.8 Boehringer Ingelheim: Revenue Forecast 2016-2026
4.5 Fareva
4.5.1 Fareva Has 35 Years’ Manufacturing Experience
4.5.2 Revenue Growth through Acquisitions: 2010-2015
4.5.3 Fareva SWOT Analysis: 2016-2026
4.5.4 Fareva Revenue Forecast: 2016-2026
4.6 Aenova Group
4.6.1 Acquisition of Haupt Creates European CMO Giant
4.6.2 Aenova’s Ever Expanding Manufacturing Capacity
4.6.3 Aenova’s Revenue 2010-2015: Organic Growth and Acquisitions
4.6.4 Aenova’s Competitive Position in the Contract Manufacturing Market: SWOT Analysis 2016
4.6.5 Becoming a Leading Contract Manufacturer: Aenova Revenue Forecast 2016-2026
4.7 Famar
4.7.1 Famar Is an Expert in Lyophilisation
4.7.2 Sustained Growth in Famar’s Revenue: 2010-2015
4.7.3 Expanding Outside Europe
4.7.4 Further Site Acquisitions Are an Opportunity for Growth 2016-2026
4.7.5 How Will Famar Perform 2016-2026?
4.8 Vetter Pharmaceutical
4.8.1 Vetter is an Injectable Manufacturing Specialist
4.8.2 Rapidly Growing Revenue in the US and Germany: 2010-2015
4.8.3 Services, Collaborations and Differentiating Factors
4.8.4 Expanding Services in US and Asia
4.8.5 Biologics Are an Opportunity for Growth for Vetter 2016-2026
4.8.6 Vetter Outlook: Revenue Forecast 2016-2026
4.9 Almac Group
4.9.1 Almac’s Manufacturing Services
4.9.2 Almac Outpaces the Market: 2011-2015
4.9.3 Almac Adding Capacity Globally
4.9.4 New Services Added 2012-2015
4.9.5 Almac Group: Contract Manufacturing Market Outlook 2016-2026
4.9.6 How Will Almac Group Perform 2016-2026?
4.10 Delpharm
4.10.1 Finished Dosage Form Manufacturing for Developed Markets
4.10.2 Delpharm: Rapid Revenue Growth Via Acquisitions, 2010-2015
4.10.3 Delpharm: Outlook and Prospects for Growth 2016-2026
4.10.4 Generics Will Drive Revenue Growth for Delpharm 2016-2026
4.11 Siegfried
4.11.1 Siegfried’s Acquisitions, 2010-2015
4.11.2 Expanding Siegfried’s Manufacturing Footprint Globally
4.11.3 Expanding High Potency API Capabilities
4.11.4 Siegfried: Financial Performance 2010-2015
4.11.5 Siegfried’s Characteristics within the Contract Manufacturing Market: SWOT Analysis 2016
4.11.6 Continued Revenue Growth for Siegfried 2016-2026
4.12 Corden Pharmaceutical
4.12.1 CordenPharma Service Division
4.12.2 CordenPharma Emerging in the API Market
4.12.3 Investments in Highly Potent Capabilities
4.12.4 CordenPharma: SWOT Analysis 2016-2026
4.13 Recipharm
4.13.1 Contract Development and Manufacturing Services
4.13.2 Recipharm: Financial Performance 2010-2015
4.13.3 Recipharm Invests in Facility Expansion
4.13.4 Recipharm Growing in the Development and Technology Market Through Acquisitions
4.13.5 Recipharm: Opportunities for Growth 2016-2026
4.13.6 Outlook for Recipharm: Revenue Forecast 2016-2026
4.14 Aesica Pharmaceuticals
4.14.1 Aesica Manufactures APIs and Finished Dosage Forms
4.14.2 Acquisitions Drive Revenue Growth but Operational Margins Have Declined, 2010-2015
4.14.3 Partnering with Academia for Innovative Solutions
4.14.4 Growth through Acquisitions and Internal Expansion
4.14.5 Aesica: Opportunities for Expansion 2016-2026
4.14.6 Forecast Aesica Financial Performance, 2016-2026
5. Leading Japanese Pharma Contract Manufacturing Organisations
5.1 Nipro Corporation: Japan’s Leading CMO
5.1.1 Nipro Pharmaceutical Contract Manufacturing Capabilities
5.1.2 Nipro: Decline in Revenue But increasing Operating Profits 2010-2015
5.1.3 Biosimilars and Anti-Cancer Drugs Are Opportunities for Future Growth: SWOT Analysis 2016-2026
5.1.4 Nipro Revenue and Profitability Forecast 2016-2026
5.2 Daito Pharmaceutical
5.2.1 Daito Has a Portfolio of More than 30 APIs
5.2.2 Rapid Growth in Revenue and Operational Profit: Daito Financial Performance 2010-2015
5.2.3 Daito Is Well-Placed for Asian Market Growth – SWOT Analysis 2016-2026
5.2.4 Sustained Growth in Revenue and Operating Profit for Daito, 2016-2026
6. Leading Developed-Market API Specialists
6.1 Teva API
6.1.1 API Manufacturing Services
6.1.2 Teva API: Financial Performance 2010-2015
6.1.3 Building a Footprint in Mexico, India and China
6.1.4 Teva API: SWOT Analysis 2016-2026
6.1.5 Outlook for Teva API: Revenue Forecast 2015-2025
6.2 Esteve Química
6.2.1 Esteve Química Manufactures APIs for Developed and Emerging Markets
6.2.2 Expanding in The US, 2015
6.2.3 Esteve Química: SWOT Analysis 2016-2026
6.3 Euticals
6.3.1 Euticals Manufactures More than 200 APIs
6.3.2 Acquisitions Drive Growth 2010-2015
6.3.3 Adding Capacity for Finished Dosage Forms
6.3.4 Asian Expansion Is an Opportunity for Growth 2016-2026
6.3.5 Euticals: Revenue Forecast 2016-2026
7. Leading Chinese Pharmaceutical Conctract Manufacturers
7.1 Zhejiang Hisun Pharmaceutical
7.1.1 API Manufacturing for Markets Worldwide
7.1.2 Zhejiang Hisun’s Rapid Growth in API Revenue Grows, 2010-2015
7.1.3 Moving Into International Drug Marketing
7.1.4 Zhejiang Hisun: Opportunities for Growth 2016-2026
7.1.5 Zhejiang Hisun: Strong API Revenue Growth 2016-2026
7.2 Zhejiang Huahai Pharmaceuticals
7.2.1 Zhejiang Huahai Is a Market Leader Within The Antihypertensive API Market
7.2.2 Zhejiang Huahai: Contract Manufacturing Performance 2010-2015
7.2.3 Expanding in the US Generic Drugs Market
7.2.4 Zhejiang Huahai: SWOT Analysis, 2016-2026
7.2.5 Zhejiang Huahai: Revenue Forecast, 2016-2026
7.3 Shandong Xinhua Pharmaceutical
7.3.1 Experience in APIs and Finished Dosage Forms
7.3.2 Shandong Xinhua: Strong Revenue Growth 2010-2015
7.3.3 Growing through Joint Ventures
7.3.4 Looking to Expand in the US and EU 2016-2026
7.3.5 Shandong Xinhua Pharmaceutical: Revenue Forecast 2016-2026
8. Leading Indian Pharmaceutical Contract Manufacturers
8.1 Aurobindo Pharma
8.1.1 API Manufacturing Services
8.1.2 Aurobindo Pharma: Steady Revenue Growth 2010-2015
8.1.3 Aurobindo Expanding Outside of Antibacterials
8.1.4 Aurobindo: Opportunities for Expansion 2016-2026
8.1.5 How Will Aurobindo’s Contract Manufacturing Division Perform 2016-2026?
8.2 Divis Laboratories
8.2.1 Divis Laboratories and the Contract Manufacturing Industry
8.2.2 Divis Laboratories: A Rapidly Growing CMO, 2010-2014
8.2.3 Divis Laboratories: API Manufacturing Outlook 2016-2026
8.2.4 Divis Laboratories: API Manufacturing Revenue Forecast, 2016-2026
8.3 Dr. Reddy’s Laboratories
8.3.1 API and FDF Manufacturing Services
8.3.2 Dr. Reddy’s PSAI: Strong Revenue Growth 2011-2015
8.3.3 Advancing in Complex Drug Manufacturing
8.3.4 Expanding in the European Manufacturing Market
8.3.5 Dr. Reddy’s PSAI Division: Revenue Forecast 2016-2026
9. Conclusions of the Study
9.1 What Has Driven Growth for CMO Market Leaders in Recent Years?
9.2 Strategies for Growth: Prospects For Leading CMOs, 2016-2026
9.3 High Demand for Biopharmaceutical Manufacturing Services
9.4 Investing in Novel Technologies
9.5 Outlook for API Manufacturers
【レポート販売概要】
■ タイトル：医薬品リーダーシリーズ：医薬品製造受託機関（CMO）上位30社2016-2026■ 英文：Pharma Leader Series: Top 30 Pharmaceutical Contract Manufacturing Organisations (CMOs) 2016-2026
■ 発行日：2016年9月
■ 調査会社：visiongain
■ 商品コード：VGAIN61121
■ 調査対象地域：グローバル
- 太陽熱温水器の世界市場2017-2021About Solar Water Heater A solar water heater comprises solar collectors and storage tanks. It uses sunlight to heat water and is generally installed on the roof of a building. Two types of solar water heaters are available in the market: active and passive. While the active type uses pumps to circulate water, the passive type does not require any pumps or control units to circulate water. Unlike …
- 香味料と香料の世界市場分析：製品別（ナチュラル、アロマ）、用途別（香味料、香料）、地域別（北アメリカ、ヨーロッパ、アジア太平洋、中東、アフリカ、中南米）、セグメント予測、2014-2025The global flavors and fragrance market is expected to reach USD 28.65 billion by 2025, according to a new report by Grand View Research, Inc. Flavors & fragrances provide lasting sensory impressions, often determined when subtly applied via food, beverage, medical products, and other substances. These products enhance the overall appeal and aesthetic value of consumer goods. Flavors & fragrances …
- 硬質プラスチック包装の世界市場2015-2025The surging economies in the developing nations, the expansion of the on-the-go lifestyle and the ageing population are significantly increasing demand for more convenient, easy-to-carry, light, safe and functional packaging, without comprising on the barrier properties and cost effectiveness. This has given rise to a boom in the rigid plastic packaging market as rigid plastic is a light, malleabl …
- 化学品倉庫保管・貯蔵の世界市場2016-2020About Chemical Warehousing and Storage Chemical warehouses are mainly used to store various chemicals used in industries. Most industries produce or use chemicals derived from oil and natural gas. Many intermediate chemicals are also produced during their production processes, which are used in other industries. The storage and handling of different chemicals require trained professionals and high …
- 二次電池の世界市場：鉛電池、リチウムイオン電池、NiCd電池、NiMH電池About Rechargeable Battery Lead-acid batteries are the dominant battery technology in the rechargeable battery segment. Lead-acid batteries are used in automotive, stationary, and deep-cycle batteries. It provides quick thrust of power (cold cranking amperes, CCA) in a short time, suitable for SLI applications. Technavio’s analysts forecast the global rechargeable battery market to grow at a CAGR …
- ブラジル・ロシア・インド・中国の核画像装置（医療機器）市場動向（～2020）BRIC Nuclear Imaging Equipment Market Outlook to 2020 Summary GlobalData’s new report, "BRIC Nuclear Imaging Equipment Market Outlook to 2020", provides key market data on the BRIC Nuclear Imaging Equipment market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories – Positron Emission Tomography Systems (PET …
- Canadian Oil Sands Limited：石油・ガスの開発・生産動向及びコスト分析– Q4, 2012Canadian Oil Sands Limited Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2012 Summary Canadian Oil Sands Limited Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essent …
- 心調律管理（CRM）医療装置のグローバル市場（2012-2018）The Cardiac Rhythm Management Devices market value is expected to reach US$20.9 billion by 2017, primarily supported by the product types - Cardiac Defibrillators, Cardiac Pacemakers Devices and Cardiac Resynchronization Therapy. Globally, Cardiac Defibrillators and Pacemakers Devices together account for approximately 80% of the market share to support the Cardiac Rhythm Management Devices Indust …
- セキュリティサービスの世界市場：マネージドセキュリティサービス、セキュリティコンサルティング、SaaSセキュリティ、脅威情報セキュリティAbout Security Services Security services focus on the security of key parameters such as data protection, compliance, architecture, email and web security, governance, data loss prevention, and identity and access. They provide features such as encryption, endpoint monitoring, identity and access management, intrusion detection, vulnerability scanning, and application and messaging security. They …
- 自動車用パワーテールゲート装置の世界市場2017-2021About Automotive Power Tailgate System A power tailgate system is a device that aids the opening and closing a car’s tailgate or boot lid automatically. The tailgate can be opened and closed by pressing a button in the dashboard, using a remote controller, or through gestures, which are tracked by sensors placed beneath the rear bumper. The system consists of mechatronic components that are enclos …
- 世界主要国における卵巣癌（Ovarian Cancer）治療市場（～2020）Ovarian Cancer Therapeutics in Major Developed Markets to 2020 - Late-Stage Pipeline Focuses on Improved Progression Free-Surival and Targeted Therapies Summary GBI Research, has released the pharma report -"Ovarian Cancer Therapeutics in Major Developed Markets to 2020 - Late-Stage Pipeline Focuses on Improved Progression Free-Surival and Targeted Therapies". The current Ovarian cancer therapeuti …
- 米タンパク質の世界市場分析：製品別（アイソレート、コンセントレート）、用途別（食品・飲料、医薬品、化粧品）、有機米タンパク質 用途別、地域別、セグメント予測、2014-2025The global rice protein market is expected to reach USD 198.5 million by 2025, according to a new report by Grand View Research, Inc. Growing global food and beverage industry has been one of the major drivers of the rice protein market. Increased consumption of functional foods such as sports & energy drinks, energy bars, and dietary supplements have also contributed to the industry growth. These …
- ICT予算及び人員配置動向：教育産業部門 – 企業のICT投資計画Why was the report written? In order to provide a depth of insight into ICT vendors’ and service providers’ potential customers. What is the current market landscape and what is changing? The education sector has come a long way in terms of ICT adoption, from the selective usage of technology to mainstream adoption. The use of ICT promises to change the way that education is imparted, with institu …
- TurkeyのBinoculars市場：貿易（輸入、輸出）動向This market research report examines the foreign trade of Turkey and its perspectives on the global market for binoculars. The report will be of considerable interest primarily to relevant strategic planners, senior company officials and importers/exporters, since it features invaluable information on binoculars export/import operations in Turkey. The 2002-2012 period is covered, with more emphasi …
- 世界の押出ポリスチレン市場：用途別（基礎（地下および地下）、屋根、壁、床、天井）、エンドユーズ別（住宅、商業）、地域別（ヨーロッパ、北アメリカ、APAC、中東＆アフリカ、南アメリカ）“The global extruded polystyrene market size is projected to grow at a CAGR of 4.0% between 2019 and 2024, in terms of value.” The global XPS market size is projected to grow from USD 5.5 billion in 2019 to USD 6.7 billion by 2024, at a CAGR of 4.0% during the same period. The increasing infrastructure spending in line with numerous government initiatives across the world and the additional insula …
